151 related articles for article (PubMed ID: 18496232)
1. Circulating glucocorticoid bioactivity during peroral glucocorticoid treatment in children and adolescents with inflammatory bowel disease.
Vihinen MK; Raivio T; Verkasalo M; Jänne OA; Kolho KL
J Clin Gastroenterol; 2008 Oct; 42(9):1017-24. PubMed ID: 18496232
[TBL] [Abstract][Full Text] [Related]
2. Circulating adiponectin as a marker for glucocorticoid-related side effects in children and adolescents with inflammatory bowel disease.
Vihinen MK; Kolho KL; Jänne OA; Andersson S; Raivio T
J Pediatr Gastroenterol Nutr; 2009 Apr; 48(4):504-6. PubMed ID: 19322063
[TBL] [Abstract][Full Text] [Related]
3. Intra-articular corticoid injection induces circulating glucocorticoid bioactivity and systemic immune activation in juvenile idiopathic arthritis.
Rintamäki H; Tamm K; Vaarala O; Sidoroff M; Honkanen V; Raivio T; Jänne O; Kolho KL
Scand J Rheumatol; 2011; 40(5):347-53. PubMed ID: 21619491
[TBL] [Abstract][Full Text] [Related]
4. Circulating glucocorticoid bioactivity in the preterm newborn after antenatal betamethasone treatment.
Kajantie E; Raivio T; Jänne OA; Hovi P; Dunkel L; Andersson S
J Clin Endocrinol Metab; 2004 Aug; 89(8):3999-4003. PubMed ID: 15292340
[TBL] [Abstract][Full Text] [Related]
5. Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease.
Kolho KL; Raivio T; Lindahl H; Savilahti E
Scand J Gastroenterol; 2006 Jun; 41(6):720-5. PubMed ID: 16716972
[TBL] [Abstract][Full Text] [Related]
6. Glucocorticoids in the treatment of children with acute lymphoblastic leukemia and hodgkin's disease: a pilot study on the adverse psychological reactions and possible associations with neurobiological, endocrine, and genetic markers.
Felder-Puig R; Scherzer C; Baumgartner M; Ortner M; Aschenbrenner C; Bieglmayer C; Voigtländer T; Panzer-Grümayer ER; Tissing WJ; Koper JW; Steinberger K; Nasel C; Gadner H; Topf R; Dworzak M
Clin Cancer Res; 2007 Dec; 13(23):7093-100. PubMed ID: 18056188
[TBL] [Abstract][Full Text] [Related]
7. Circulating glucocorticoid bioactivity and serum cortisol concentrations in premature infants: the influence of exogenous glucocorticoids and clinical factors.
Nykänen P; Raivio T; Heinonen K; Jänne OA; Voutilainen R
Eur J Endocrinol; 2007 May; 156(5):577-83. PubMed ID: 17468194
[TBL] [Abstract][Full Text] [Related]
8. Termination of pregnancy with mifepristone and prostaglandin suppresses transiently circulating glucocorticoid bioactivity.
Heikinheimo O; Raivio T; Honkanen H; Ranta S; Jänne OA
J Clin Endocrinol Metab; 2003 Jan; 88(1):323-6. PubMed ID: 12519872
[TBL] [Abstract][Full Text] [Related]
9. Budesonide is effective in treating lymphocytic colitis: a randomized double-blind placebo-controlled study.
Miehlke S; Madisch A; Karimi D; Wonschik S; Kuhlisch E; Beckmann R; Morgner A; Mueller R; Greinwald R; Seitz G; Baretton G; Stolte M
Gastroenterology; 2009 Jun; 136(7):2092-100. PubMed ID: 19303012
[TBL] [Abstract][Full Text] [Related]
10. Transactivation assay for determination of glucocorticoid bioactivity in human serum.
Raivio T; Palvimo JJ; Kannisto S; Voutilainen R; Jänne OA
J Clin Endocrinol Metab; 2002 Aug; 87(8):3740-4. PubMed ID: 12161504
[TBL] [Abstract][Full Text] [Related]
11. [Glucocorticoid-induced diabetes mellitus in gastrointestinal diseases].
Kern W; Stange EF; Fehm HL; Klein HH
Z Gastroenterol; 1999 Jun; Suppl 1():36-42. PubMed ID: 10444814
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoid dose dependent downregulation of glucocorticoid receptors in patients with rheumatic diseases.
Sanden S; Tripmacher R; Weltrich R; Rohde W; Hiepe F; Burmester GR; Buttgereit F
J Rheumatol; 2000 May; 27(5):1265-70. PubMed ID: 10813299
[TBL] [Abstract][Full Text] [Related]
13. IL-6 may modulate the skeletal response to glucocorticoids during exacerbations of inflammatory bowel disease.
Kriel M; Sayers A; Fraser WD; Williams AM; Koch A; Zacharowski K; Probert CS; Tobias JH
Calcif Tissue Int; 2010 May; 86(5):375-81. PubMed ID: 20229252
[TBL] [Abstract][Full Text] [Related]
14. Fracture risk associated with systemic and topical corticosteroids.
Vestergaard P; Rejnmark L; Mosekilde L
J Intern Med; 2005 Apr; 257(4):374-84. PubMed ID: 15788008
[TBL] [Abstract][Full Text] [Related]
15. The anti-inflammatory effects of inhaled corticosteroids versus anti-leukotrienes on the lymphocyte P-glycoprotein (PGP) expression in asthmatic children.
Kopriva F; Dzubak P; Potesil J; Hajduch M
J Asthma; 2009 May; 46(4):366-70. PubMed ID: 19484671
[TBL] [Abstract][Full Text] [Related]
16. Screening for adrenal suppression in children with inflammatory bowel disease discontinuing glucocorticoid therapy.
Sidoroff M; Kolho KL
BMC Gastroenterol; 2014 Mar; 14():51. PubMed ID: 24661924
[TBL] [Abstract][Full Text] [Related]
17. Bone turnover and metabolism in paediatric patients with inflammatory bowel disease treated with systemic glucocorticoids.
Vihinen MK; Kolho KL; Ashorn M; Verkasalo M; Raivio T
Eur J Endocrinol; 2008 Dec; 159(6):693-8. PubMed ID: 18787051
[TBL] [Abstract][Full Text] [Related]
18. A randomized, masked comparison of topical ketorolac 0.4% plus steroid vs steroid alone in low-risk cataract surgery patients.
Wittpenn JR; Silverstein S; Heier J; Kenyon KR; Hunkeler JD; Earl M;
Am J Ophthalmol; 2008 Oct; 146(4):554-560. PubMed ID: 18599019
[TBL] [Abstract][Full Text] [Related]
19. Clinical impact of corticosteroid-induced adrenal suppression during treatment for acute lymphoblastic leukemia in children: a prospective observational study using the low-dose adrenocorticotropin test.
Rix M; Birkebaek NH; Rosthøj S; Clausen N
J Pediatr; 2005 Nov; 147(5):645-50. PubMed ID: 16291357
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of a rocuronium-induced neuromuscular block in patients receiving prednisolone.
Soltész S; Mencke T; Stunz M; Diefenbach C; Ziegeler S; Molter GP
Acta Anaesthesiol Scand; 2009 Apr; 53(4):443-8. PubMed ID: 19317861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
